Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | -0.50% | +0.51% | -4.35% |
Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
Apr. 30 | Tianjin Pharmaceutical's Q1 Attributable Profit Slips 3% | MT |
Business Summary
Number of employees: 4,619
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chinese Patent Medicine
71.0
%
| 5,652 | 68.5 % | 5,836 | 71.0 % | +3.26% |
Western Medicine
20.6
%
| 1,783 | 21.6 % | 1,697 | 20.6 % | -4.84% |
Other
8.2
%
| 796 | 9.7 % | 673 | 8.2 % | -15.47% |
Other Business
0.2
%
| 18 | 0.2 % | 16 | 0.2 % | -9.16% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.5
%
| 8,198 | 99.6 % | 8,161 | 99.5 % | -0.44% |
Overseas
0.5
%
| 34 | 0.4 % | 45 | 0.5 % | +33.00% |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 19-09-29 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Jian Hua Xing
BRD | Director/Board Member | 53 | 21-12-09 |
Mai Wang
BRD | Director/Board Member | 54 | 17-07-31 |
Xiu Mei Guo
BRD | Director/Board Member | 42 | 18-12-23 |
Yuan Xi Wang
CHM | Chairman | 46 | 19-12-01 |
Li Qing
BRD | Director/Board Member | 57 | 21-05-16 |
Min Guo
BRD | Director/Board Member | 53 | 21-09-05 |
Ming Rui Zhang
CHM | Chairman | 49 | 21-12-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 200,000,000 | 0 | 0 | 31.14 % |
Stock B | 1 | 570,158,276 | 239,803,030 ( 42.06 %) | 1,285,200 ( 0.2254 %) |
Company contact information
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
No. 17 Baidi Road Nankai District
300193, Tianjin
+
http://www.jydrt.com.cn/Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B | |
+39.87% | 1.44B |
- Stock Market
- Equities
- 600329 Stock
- T14 Stock
- Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited